Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment. (April 2018) - Suppan, C.; Brcic, I.; Heitzer, E.; Tiran, V.; Mueller, H.D.; Auer, M.; Cote, R.J.; Datar, R.; Dandachi, N.; Balic, M.